10 September 2023 - The quality-adjusted life-year (QALY) is an international standard in cost-effectiveness analysis. A known concern arises from the ...
18 April 2023 - For decades, many US authors of cost effectiveness analyses referenced a common benchmark or threshold—$50 000 per quality-adjusted ...
8 September 2021 - Researchers and policy makers in the US are exploring the implementation of health technology assessment and value ...
16 July 2021 - Biogen officials defended the company's Alzheimer's drug and criticised ICER's cost effectiveness report today at a meeting ...
19 June 2021 - The Institute for Clinical and Economic Review is an independent organisation that reviews drugs and devices with ...
7 May 2021 - A key element in the long-simmering debate on reining in drug prices in the United States ...
2 December 2020 - Independent panel members debate the evidence on the effectiveness and value of new drugs and other ...
19 November 2020 - Prices send signals about consumer preferences and thus stimulate producers to make more of what people want. ...
3 November 2020 - Cost effectiveness analysis is an important tool for informing treatment coverage and pricing decisions, yet no consensus ...
23 June 2020 - In the span of mere weeks, the novel coronavirus (COVID-19) has upended modern life. Schools and businesses ...
19 June 2020 - Public input on drugs of concern will be accepted through 17 July 2020. ...
15 June 2020 - As pharmaceutical and biotech companies scramble to identify treatments for COVID-19, a new disease that initially ...
2 June 2020 - Innovative medical products offer significant and potentially transformative impacts on health, but they create concerns about rising ...
1 June 2020 - Cost effectiveness analyses, which are often conducted to evaluate new medicines, use a standardised framework to ...
20 May 2020 - On April 29, the National Institutes of Health announced that in a placebo-controlled trial of patients with ...